TNF and major depressive disorder: In summary, our findings suggest that the future diagnosis and treatment of MDD should consider inflammatory markers in people with depressive symptoms and further explore their association with specific depressive symptoms, especially the effects of IL-1β and TNF-α, and knowledge of the effects of inflammation modification.